Physician Wealth Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Physician Wealth Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.32K	Buy	+15	New	+$1.56K	﹤0.01%	1790

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Physician Wealth Advisors's DNTH Position: Q3 2026 in Review

Physician Wealth Advisors opened a new position in Dianthus Therapeutics (DNTH) in Q3 2026: 15 shares worth $1.32K. The stake represents ﹤0.01% of the portfolio and ranks #1790 among its holdings.

109 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

Physician Wealth Advisors held 15 shares of Dianthus Therapeutics worth $1.32K as of Q3 2026.
Dianthus Therapeutics was a new Physician Wealth Advisors position in Q3 2026.
Dianthus Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1790 holding.
109 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.